NL-OMON20255已完成不适用
A double blind placebo controlled study on the effect of cerivastatin on the process of atherosclerosis in non-insulin dependent diabetes mellitus.
eiden University Medical Center, Dept. of General Internal Medicine and dept. of Cardiology.0 个研究点目标入组 250 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV. Diabetes Care 2004;27:2887-92.
-Beishuizen ED, Tamsma JT, Jukema JW, van de Ree MA, van der Vijver JC, Meinders AE, Huisman MV. Diabetes Care 2005;28:1668-74.
-Beishuizen ED, Jukema JW, Tamsma JT, van de Ree MA, van der Vijver JC, Putter H, Maan AC, Meinders AE, Huisman MV. Diabetes Care 2005;28:1675-9.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patient with Non-Insulin Dependent Diabetes Mellitus. The diagnosis based upon the age of onset, the presence of obesity and the absence of ketoacidosis at the time of diagnosis and the use of diet or oral anti-diabetic drugs for more than one year from diagnosis;
- •2. Males and females;
排除标准
- •1. Angina pectoris;
- •2. History of myocardial infarction, PTCA or CABG;
研究者
相似试验
已完成
不适用
Study to assess the effect of an added Synbiotic mixture on Atopic dermatitis in INfanTs.Atopic DermatitisNL-OMON23678This clinical study will be performed within TOP Institute Pharma (project T1-501). Besides Danone Research, also the Academic Medical Center (AMC) Amsterdam, Wilhelmina Children's Hospital (WKZ) Utrecht, VU University Amsterdam, and the Utrecht Institute for Pharmaceutical Sciences (UIPS) will participate in the TOP Institute Pharma project. Danone Research shall take care of the Sponsor responsibilities as defined by ICH-GCP'.144
已完成
不适用
A double-blind placebo-controlled study on the effect of cerivastatin on the process of atherosclerosis in non-insulin-dependent diabetes mellitusDiabetes mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN51822988eiden University Medical Centre (LUMC) (Netherlands)250
已完成
2 期
Evaluating the safety and efficacy of CCX354-C in subjects with rheumatoid arthritis partially responsive to methotrexate therapyMusculoskeletal DiseasesOther rheumatoid arthritisRheumatoid arthritisISRCTN67054656ChemoCentryx, Inc. (USA)150
已完成
2 期
Fulvestrant and vandetanib in advanced aromatase inhibitor resistant breast cancerCancerMetastatic breast cancerISRCTN13663157Velindre NHS Trust165
尚未招募
不适用
Een dubbelblind, placebo-gecontroleerd fase 2 onderzoek naar de effecten van ARA 290 op neuropathische symptomen in patiënten met type 2 diabetes.NL-OMON21147eiden University Medical Center50